CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms. (Q34485103)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.
scientific article

    Statements

    CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms. (English)
    Sara C Meyer
    Matthew D Keller
    Sophia Chiu
    Priya Koppikar
    Olga A Guryanova
    Franck Rapaport
    Katia Manova
    Dmitry Pankov
    Richard J O'Reilly
    Maria Kleppe
    Anna Sophia McKenney
    Alan H Shih
    Kaitlyn Shank
    Eftymia Papalexi
    Barbara Spitzer
    Nick Socci
    Agnes Viale
    Emeline Mandon
    Nicolas Ebel
    Rita Andraos
    Joëlle Rubert
    Ernesta Dammassa
    Vincent Romanet
    Arno Dölemeyer
    Michael Zender
    Melanie Heinlein
    Raajit Rampal
    Rona Singer Weinberg
    Ronald Hoffman
    William R Sellers
    Francesco Hofmann
    Masato Murakami
    Fabienne Baffert
    Christoph Gaul
    Thomas Radimerski
    Ross L Levine

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit